InChI=1S/C20H35NO15/c1- 5-10(25)12(27)14(29)19(32-5)36-17-9(21-6(2)24)18(31)33-8(4-23)16(17)35-20-15(30)13(28)11(26)7(3-22)34-20/h5,7-20,22-23,25-31H,3-4H2,1-2H3,(H,21,24)/t5-,7+,8+,9+,10+,11-,12+,13-,14-,15+,16+,17+,18?,19-,20-/m0/s1 |
| HBBOZFUQJDYASD-QGTNPELVSA-N |
| C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(C)=O)C(O)O[C@H](CO)[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@@H]1O |
|
|
antigen
Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC).
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
|
|
|
α-L-fucopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-D-glucopyranose
|
|
(Gal)1 (GlcNAc)1 (LFuc)1
|
KEGG GLYCAN
|
|
3-FL
|
KEGG GLYCAN
|
|
3-Fucosyllactosamine
|
KEGG GLYCAN
|
|
6-deoxy-α-L-galactopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-D-glucopyranose
|
IUPAC
|
|
α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-D-GlcNAc
|
ChEBI
|
|
α-L-fucopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-(acetylamino)-2-deoxy-D-glucopyranose
|
IUPAC
|
|
α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-D-glucosamine
|
ChEBI
|
|
α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc
|
ChEBI
|
|
β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-D-GlcNAc
|
ChEBI
|
|
β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-D-glucosamine
|
ChEBI
|
|
β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-D-glucosamine
|
UniProt
|
|
Galβ1-4(Fucα1-3)GlcNAc
|
ChEBI
|
|
Lewis x antigen
|
KEGG GLYCAN
|
|
Lewisx
|
ChEBI
|
|
Lex
|
ChEBI
|
|
Lex
|
ChEBI
|
|
Tetraantennary neutral lactosaminoglycan
|
KEGG GLYCAN
|
|
WURCS=2.0/3,3,2/[a2122h-1x_1-5_2*NCC/3=O][a1221m-1a_1-5][a2112h-1b_1-5]/1-2-3/a3-b1_a4-c1
|
GlyTouCan
|
